Your shopping cart is currently empty

FL118 is a novel survivin inhibitor that inhibits cancer stem cell-like properties.FL118 is a novel camptothecin analog with anticancer activity that inhibits epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway, thereby inhibiting migration and invasion of human breast cancer cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $73 | In Stock | In Stock | |
| 5 mg | $156 | In Stock | In Stock | |
| 10 mg | $197 | In Stock | In Stock | |
| 25 mg | $396 | In Stock | In Stock | |
| 50 mg | $488 | In Stock | In Stock | |
| 100 mg | $787 | - | In Stock |
| Description | FL118 is a novel survivin inhibitor that inhibits cancer stem cell-like properties.FL118 is a novel camptothecin analog with anticancer activity that inhibits epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway, thereby inhibiting migration and invasion of human breast cancer cells. |
| In vitro | FL118 (0-200 nM; 24, 48, and 72 h) suppresses cell proliferation and migration in ES-2 and SK-O-V3 cells, influencing CYGB expression and inhibiting the PI3K/AKT/mTOR pathway, altering vimentin and E-cadherin levels in ovarian cancer cells. FL118 (0-500 nM; 0-72 h) induces dephosphorylation and degradation of DDX5, regulating survivin, McL-1, XIAP, cIAP2, c-Myc, and mKras expression. FL118 (0-1 μM; 24, 48 h) exhibits cytotoxicity against A549, MDA-MB-231, and RM-1 cell lines, enhancing PARP cleavage and triggering apoptosis in A549 cells, primarily arresting them at the G2/M phase. |
| In vivo | FL118 (5 and 10 mg/kg; p.o.; once a week; 20 days; female BALB/c nude mice) dose-dependently suppressed ES-2 tumor growth by upregulating CYGB expression.[1] Additionally, FL118 (0-1.5 mg/kg; i.p.; once every other day; five times) effectively eliminated human colon and head-and-neck tumors resistant to irinotecan or topotecan.[4] FL118 (1.5 mg/kg; i.v.; once) also demonstrated favorable pharmacokinetic profiles.[4] |
| Synonyms | FL-118, FL 118, 10,11-(Methylenedioxy)-20(S)-camptothecin |
| Molecular Weight | 392.36 |
| Formula | C21H16N2O6 |
| Cas No. | 135415-73-5 |
| Smiles | C(C)[C@]1(O)C2=C(C(=O)N3C(=C2)C=4C(C3)=CC=5C(N4)=CC6=C(C5)OCO6)COC1=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| Solubility Information | DMSO: 2 mg/mL (5.1 mM), Sonication and heating are recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
| ||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.